Faron Pharmaceuticals is Drug Discovery in Finland that focus on Faron Pharmaceuticals Oy business. Founded in 2007. They cover business area such as Faron Pharmaceuticals Oy, novel treatment, medical condition, unmet need, a pipeline, immune response, oncology and organ damage, Clevegen, bexmarilimab, its investigative precision immunotherapy, phase, /II, patient, untreatable solid tumour, immune suppression, immune activation, Traumakine, several Phase III study.
2007
( 17 years old in 2024 )
Faron Pharmaceuticals Oy
-
Joukahaisenkatu 6
20520 Turku
Finland
Private
Faron Pharmaceuticals Oynovel treatmentmedical conditionunmet needa pipelineimmune responseoncology and organ damageClevegenbexmarilimabits investigative precision immunotherapyphase/IIpatientuntreatable solid tumourimmune suppressionimmune activationTraumakineseveral Phase III study
* We use standard office opening hours in near Faron Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Faron Pharmaceuticals is Drug Discovery business from Finland that founded in 2007 (17 years old in 2024), Faron Pharmaceuticals business is focusing on Faron Pharmaceuticals Oy.
Faron Pharmaceuticals headquarter office and corporate office address is located in Joukahaisenkatu 6 20520 Turku Finland.
Faron Pharmaceuticals was founded in Finland.
In 2024, Faron Pharmaceuticals is currently focus on Faron Pharmaceuticals Oy sector.
Above is snippet of Google Trends for "Faron Pharmaceuticals Oy" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Faron Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.